Ivan Mascanfroni, n/a

Senior Director Immunology
Seismic Therapeutic

Poster(s):

• W138 - Preclinical Polypharmacology of S-1117, a Novel Engineered Fc-Fused IgG Degrading Enzyme, for Chronic Treatment of Autoantibody-Mediated Diseases
  Wednesday, June 25, 2025

  7:30am - 7:30pm East Coast USA Time

• Th101 - Discovery and Characterization of a Novel Engineered Fc-fused IgE Cleaving Enzyme for Treatment of IgE Mediated Diseases
  Thursday, June 26, 2025

  7:30am - 7:45pm East Coast USA Time

• Tu119 - Characterization of S-1117, a Novel pan-IgG Protease Engineered by IMPACT Platform to Reduce Immunogenicity
  Tuesday, June 24, 2025

  6:00pm - 7:30pm East Coast USA Time